Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence
The WisdomTree India Earnings ETF (EPI) is drawing strong investor attention as India’s economy accelerates, offering a compelling chance to invest in some of the nation’s most lucrative companies. Yet, potential investors should remain mindful of ongoing market volatility and valuation challenges when weighing this opportunity
